Telehealth practitioners must take note of the DEA’s proposed rule making that would impact the way telehealth practitioners can prescribe controlled substances.

The Ryan Haight Act and the Proposed Rules

Continue Reading Telehealth Practitioners Must Be Aware of the DEA’s Proposed New Rules for Prescribing Controlled Substances via Telemedicine

Two landmark cases fraught with False Claim Act (“FCA”) allegations of fraudulent billing for prescription drugs against food and pharmacy chains are making their way from the Seventh Circuit to

Continue Reading Is it Really Fraud? The Supreme Court Will Decide

Physicians around the country are familiar with the Federal Anti-Kickback Statute (“AKS”) (42 U.S.C. § 1320a-7b(b)) and the Federal Physician Self-Referral Law, commonly referred to as the Stark Law (“Stark”)

Continue Reading Five Differences Between the Federal Anti-Kickback Statute and the Federal Stark Law

On January 5, 2023, the Federal Trade Commission (“FTC”) published a Notice of Proposed Rulemaking (“NPRM”) which would broadly prohibit companies from entering into or enforcing non-competition agreements or clauses

Continue Reading FTC Proposes Broad Rule Banning Non-Compete Covenants with Physicians and Other Healthcare Workers